ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAC0.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $855,000 | +16.9% | 1,500,000 | 0.0% | 1.08% | -44.5% |
| Q4 2023 | $731,250 | -16.7% | 1,500,000 | 0.0% | 1.95% | +147.4% |
| Q3 2023 | $877,500 | -10.6% | 1,500,000 | 0.0% | 0.79% | -21.6% |
| Q2 2023 | $981,750 | -0.9% | 1,500,000 | 0.0% | 1.01% | +63.8% |
| Q1 2023 | $991,164 | -11.9% | 1,500,000 | 0.0% | 0.61% | -31.6% |
| Q4 2022 | $1,124,954 | +1.3% | 1,500,000 | 0.0% | 0.90% | +99.1% |
| Q3 2022 | $1,110,000 | 0.0% | 1,500,000 | 0.0% | 0.45% | +69.5% |
| Q2 2022 | $1,110,000 | -2.4% | 1,500,000 | 0.0% | 0.27% | 0.0% |
| Q1 2022 | $1,137,000 | -7.0% | 1,500,000 | 0.0% | 0.27% | +16.7% |
| Q4 2021 | $1,223,000 | 0.0% | 1,500,000 | 0.0% | 0.23% | -47.2% |
| Q3 2021 | $1,223,000 | +10.2% | 1,500,000 | 0.0% | 0.43% | -3.8% |
| Q2 2021 | $1,110,000 | +2.1% | 1,500,000 | 0.0% | 0.45% | +65.1% |
| Q1 2021 | $1,087,000 | – | 1,500,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 25,875,000 | $13,703,814 | 1.46% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 45,283,000 | $31,018,855 | 1.14% |
| Saltoro Capital, LP | 1,500,000 | $855,000 | 1.08% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 30,000,000 | $19,830,000 | 0.94% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 52,324,000 | $23,120,580 | 0.37% |
| Soros Fund Management | 27,951,000 | $15,928,716 | 0.26% |
| D. E. Shaw & Co., Inc. | 14,000,000 | $8,155,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 5,018,000 | $2,858,755 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |